Abstract
Hodgkin lymphoma (HL) is the sixth most common type of cancer during childhood, accounting for approximately 5 % of all malignancies and half of all childhood lymphomas. HL is very rare in children under 5 years of age, whereas the incidence among patients younger than 15 years is 5.5 cases per million and for those aged 15–20 years reaches 12.1 cases per million [1–3]. A characteristic bimodal curve with an early peak during adolescence and a second peak in patients aged above 50 years old is well recognized.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Gurney J, Bondy M (2006) Chapter 1. Epidemiology of childhood cancer. In: Pizzo AP, Poplack DG (eds) Principles and practice of pediatric oncology, 5th edn. Lippincott-Raven, Philadelphia, pp 1–13
Pourtsidis A, Doganis D, Baka M et al (2013) Differences between younger and older patients with childhood Hodgkin lymphoma. Pediatr Hematol Oncol 30:532–536
Pourtsidis A, Doganis D, Baka M et al (2012) Successful treatment in children with Hodgkin lymphoma in Greece; a 20-year experience in a single institution. Lymphoma 2012:Article ID 215868. doi:10.1155/2012/215868
Dinand V, Arya LS (2006) Epidemiology of childhood Hodgkin’s disease: is it different in developing countries? Indian Pediatr 43:141–147
Feldman A, Pittaluga S, Jaffe E (2006) Classification and histopathology of the lymphomas. In: Canellos G, Lister T, Young B (eds) The lymphomas, 2nd edn. Saunders Elsevier, Philadelphia, pp 2–25
Nievelstein R, Quarles van Ufford H, Kwee T et al (2012) Radiation exposure and mortality risk from CT and PET imaging of patients with malignant lymphoma. Eur Radiol 22:1946–1954
Furth C, Steffen IG, Amthauer H, Ruf J, Misch D, Schönberger S et al (2009) Early and late therapy response assessment with [18F]fluorodeoxyglucose positron emission tomography in pediatric Hodgkin’s lymphoma: analysis of a prospective multicenter trial. J Clin Oncol 27:4385–4391
Hudson M, Onciu M, Donaldson S (2006) Hodgkin’s disease. In: Pizzo P, Poplack D (eds) Principles and practise of pediatric oncology, 5th edn. Lippincott-Raven, Philadelphia, pp 695–721
Donaldson S, Link M, Weinstein H et al (2007) Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin’s disease. J Clin Oncol 25:332–337
Oguz A, Karadeniz C, Okur F et al (2005) Prognostic factors and treatment outcome in childhood Hodgkin disease. Pediatr Blood Cancer 45:670–675
Hudson M, Krasin M, Link M et al (2004) Risk-adapted, combined-modality therapy with VAMP/COP and response based, involved-field radiation for unfavorable pediatric Hodgkin’s disease. J Clin Oncol 22:4541–4550
Brusamolino E, Carella A (2007) Treatment of refractory and relapsed Hodgkin’s lymphoma: facts and perspectives. Haematologica 92:6–10
Bartlett N (2008) Modern treatment of Hodgkin lymphoma. Curr Opin Hematol 15:408–414
Hudson M, Donaldson S (1997) Chapter 21. Hodgkin’s disease. In: Pizzo P, Poplack D (eds) Principles and practice of pediatric oncology, 3rd edn. Lippincott-Raven Publishers, Philadelphia, pp 523–543
Kluge R, Körholz D (2011) Role of FDG-PET in staging and therapy of children with Hodgkin lymphoma. Klin Padiatr 223:315–319
Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M (1971) Report of the committee on Hodgkin’s disease staging classification. Cancer Res 31(11):1860
Lister TA, Crowther D, Sutcliffe SB, Glatstein E, Canellos GP, Young RC, Rosenberg SA, Coltman CA, Tubiana M (1989) Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin’s disease: Cotswolds meeting. J Clin Oncol 7(11):1630
Seth R, Puri K, Singh P, Selvam P, Kumar R (2012) The role of fluorodeoxyglucose positron emission tomography-computerized tomography in resolving therapeutic dilemmas in pediatric Hodgkin lymphoma. Indian J Nucl Med 27:141–144
Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ et al (2007) Revised response criteria for malignant lymphoma. J Clin Oncol 25:579–586
Rathore N, Eissa HM, Margolin JF et al (2012) Pediatric Hodgkin lymphoma: are we over-scanning our patients? Pediatr Hematol Oncol 29:415–423
Biasotti S, Garaventa A, Padovani P et al (2005) Role of active follow-up for early diagnosis of relapse after elective end of therapies. Pediatr Blood Cancer 45:781–786
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Doganis, D., Papaioannou, G.C., Prassopoulos, V.K. (2016). Hodgkin Lymphoma in Children. In: Andreou, J., Kosmidis, P., Gouliamos, A. (eds) PET/CT in Lymphomas. Springer, Cham. https://doi.org/10.1007/978-3-319-27380-8_18
Download citation
DOI: https://doi.org/10.1007/978-3-319-27380-8_18
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-27378-5
Online ISBN: 978-3-319-27380-8
eBook Packages: MedicineMedicine (R0)